Table 1.
Baseline sociodemographic and clinical characteristics of 268 patients positive for SARS-CoV-2
| n | % | (95% CI) | |
|---|---|---|---|
| Gender | |||
| Male | 102 | 38.1 | (32.2–44.2) |
| Female | 166 | 61.9 | (55.8–27.8) |
| Age (years) | |||
| < 40 | 79 | 29.5 | (24.1–35.3) |
| 40–54 | 103 | 38.4 | (32.6–44.5) |
| ≥ 55 | 86 | 32.1 | (26.5–38.0) |
| Smoking habits | |||
| Never | 157 | 58.6 | (52.4–64.5) |
| Former | 68 | 25.4 | (20.3–31.0) |
| Current | 43 | 16.0 | (11.9–21.0) |
| Drinking habits | |||
| Never | 176 | 65.7 | (59.7–71.3) |
| Former | 27 | 10.1 | (6.7–14.3) |
| Current | 65 | 24.3 | (19.2–29.8) |
| BMI (kg m−2) | |||
| < 25 | 146 | 54.5 | (48.3–60.5) |
| 25–29.9 | 84 | 31.3 | (25.8–37.3) |
| ≥ 30 | 38 | 14.2 | (10.2–18.9) |
| Comorbidity | |||
| None | 177 | 66.0 | (60.0–76.0) |
| Any | 91 | 34.0 | (28.3–40.0) |
| Blocked nose | |||
| 0: No | 218 | 81.3 | (76.2–85.8) |
| 1: Yes—mild-to-moderate | 35 | 13.1 | (9.3–17.7) |
| 2: Yes—severe | 15 | 5.6 | (3.2–9.1) |
| Chemosensory dysfunction | |||
| No | 81 | 30.2 | (24.8–36.1) |
| Yes | 187 | 69.8 | (63.9–75.2) |
| Type of chemosensory dysfunction | |||
| None | 81 | 30.2 | (24.8–36.1) |
| Smell | 19 | 7.1 | (4.3–10.9) |
| Taste | 16 | 6.0 | (3.5–9.5) |
| Smell and taste | 152 | 56.7 | (50.6–62.7) |
| SNOT-22 at diagnosisa | |||
| 0: No | 81 | 30.2 | (24.8–36.1) |
| 1: Very mild | 3 | 1.1 | (0.2–3.2) |
| 2: Mild or slight | 18 | 6.7 | (4.0–10.4) |
| 3: Moderate | 27 | 10.1 | (6.7–14.3) |
| 4: Severe | 40 | 14.9 | (10.9–19.8) |
| 5: As bad as it can be | 99 | 36.9 | (31.1–43.0) |
| Time for negative swab (days) | |||
| < 22 | 128 | 47.8 | (41.6–53.9) |
| ≥ 22 | 140 | 52.2 | (46.1–58.4) |
SARS-CoV-2 severe acute respiratory syndrome coronavirus
aAccording to sino-nasal outcome test 22 (SNOT-22), item “sense of smell or taste”